)
Max Healthcare Institute (543220) investor relations material
Max Healthcare Institute Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved 22nd consecutive quarter of year-on-year growth, with FY26 gross revenue up 16% to ₹10,538 crore and operating EBITDA up 14% to ₹2,638 crore; PAT after exceptional items rose 22% to ₹1,631 crore.
Phased commissioning of over 20% additional brownfield capacity across multiple hospitals, including a 400-bed Max Smart tower and 160-bed Mohali tower; all beds to be operational in 2–3 months.
Acquisition of a 58.28% stake in Kalinga Hospital completed in May 2026, marking entry into Eastern India.
Board approved INR 1,400 crore investment for a new 700–712-bed greenfield hospital in Lucknow, with commissioning expected by FY30.
Final dividend of ₹2 per equity share recommended, subject to shareholder approval.
Financial highlights
Q4 FY26 gross revenue: ₹2,664 crore, up 10% year-on-year and 2% quarter-on-quarter; operating EBITDA: ₹682 crore, up 8% year-on-year and 5% quarter-on-quarter; EBITDA margin: 26.8%.
FY26 profit after tax: ₹1,631 crore, up 22% year-over-year; consolidated net profit: ₹1,44,241 lakhs.
Free cash flow in Q4: ₹581 crore; net debt at FY26 end: ₹1,908 crore; cash from operations: ₹1,541 crore.
Pre-tax ROCE: 21.8% in FY26; consolidated basic EPS: ₹14.83 in FY26.
Network operating EBITDA margin: 26.2% for FY26; annualized EBITDA per bed: ₹73 lakh in Q4.
Outlook and guidance
Focus on scaling newly commissioned capacities, integrating Kalinga Hospital, and progressing expansion projects including Gurgaon and Lucknow.
Additional 10% bed capacity to be added with Gurugram facility later in 2026; Lucknow hospital to be commissioned by FY30.
450-bed hospital in Pune and further brownfield/asset-light expansions planned.
No major regulatory delays anticipated; some minor delays due to labor and supply issues.
- Q3 FY26 delivered strong growth, with expansion, digital gains, and regulatory impacts shaping outlook.543220
Q3 25/2612 Apr 2026 - 18% revenue growth, high occupancy, and major expansion with a new hospital in Zirakpur.543220
Q1 24/252 Feb 2026 - Strong revenue and EBITDA growth, major acquisitions, and expansion marked the quarter.543220
Q2 24/2516 Jan 2026 - Q3 FY25 revenue up 34% YoY, EBITDA up 32%, with major expansion and strong cash flow.543220
Q3 24/259 Jan 2026 - Revenue up 27% YoY, EBITDA up 23%, and PAT up 17% amid robust expansion and digital growth.543220
Q1 25/2623 Nov 2025 - FY25 revenue up 26% with strong EBITDA growth, expansion, and a recommended dividend.543220
Q4 24/2518 Nov 2025 - Q2 FY26 saw strong growth, expansion, and digital gains, supported by key divestments and a merger.543220
Q2 25/2617 Nov 2025
Next Max Healthcare Institute earnings date
Next Max Healthcare Institute earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage